PANEL 1
INCLUSIVE MEDICINE: HOW MODERN RESEARCH AMPLIFIES OUTCOMES FOR PATIENT ACCESS, INCLUSION AND DIVERSITY
Thursday, November 11th
8:30 am – 9:30 am (ET)
Moderator
Sanskriti Thakur, MBA
Chief Growth Officer
Medable, Inc.
Panelists
Dr. Yele Aluko, MD
Chief Medical Officer
EY Americas Business Consulting Health Sector
Ken Getz, MBA
Director and Professor, Tufts Center for the Study of Drug Development
Tufts University School of Medicine
Dr. Sapna McManus, MD
Head of Patient Inclusion and Health Equity, Chief Diversity Office
Genentech
FIRESIDE DISCUSSION
THE ETHICAL OBLIGATIONS OF PHARMACEUTICAL COMPANIES IN A GLOBAL HEALTH EMERGENCY – CASE STUDY: COVID-19 VACCINES
Thursday, November 11th
9:30 am – 10:00 am (ET)
Dr. Ezekiel J. Emanuel, MD, PhD
Vice Provost for Global Initiatives and Professor and Co-Director, Healthcare Transformation Institute
University of Pennsylvania
Dr. Ron Cohen, MD
President and Chief Executive Officer
Acorda Therapeutics, Inc.
PANEL 2
HIGHLY PREVALENT NEGLECTED DISEASES: DEVELOPING MEDICINES AND BUILDING INFRASTRUCTURE FOR THE REST OF THE WORLD
Thursday, November 11th
10:00 Am – 11:15 Am (ET)
Moderator
Kenneth I. Moch
Senior Advisor to the Chairman
Center for Global Health Innovation and Global Health Crisis Coordination Center
Panelists
Dr. Julie Gerberding, MD, PhD
Chief Patient Officer and Executive Vice President, Population Health and Sustainability
Merck & Co., Inc.
Dr. Mwelecele Ntuli Malecela, MSc, PhD
Director, Deportment of Control of Neglected Tropical Diseases
World Health Organization
Dr. Rajeev Venkayya, MD
President, Global Vaccines Unit
Takeda Pharmaceuticals Ltd.
Dr. Scott C. Weaver, MS, PhD
John Sealy Distinguished University Chair in Human Infections & Immunity Chair, Department of Microbiology and Immunology Director, Institute for Human Infections and Immunity; and Scientific Director Galveston National Laboratory GVN Center Director
University of Texas Medical Branch
